Stocktoria

VITASPRING BIOMEDICAL CO. LTD. VSBC

OTC · stock · Services-Commercial Physical & Biological Research · website · IPO 2019-10-01

VITASPRING BIOMEDICAL CO. LTD. statistics & valuation

Market cap as of 2026-07-02. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Gross margin (%)
69.90% 79.80% 11.20% 45.20% 36.80% 2017201820192020202120222023202420252026
Operating margin (%)
-39.30% -130.40% 45.70% 171.40% 20.10% 2017201820192020202120222023202420252026
Return on equity (%)
-1.50% 441.40% 57.70% 2017201820192020202120222023202420252026
Shares outstanding
49315 3.0M 10.9M 209.7M 209.7M 206.5M 206.5M 207.0M 207.0M 207.0M 2017201820192020202120222023202420252026
Net debt ($)
2017201820192020202120222023202420252026
Share buybacks ($)
2017201820192020202120222023202420252026
Return on assets (%)
-340.10% 3.70% 224.60% 25.20% -543.70% -814.40% -5389.60% -2830.30% 2017201820192020202120222023202420252026
Free cash flow margin (%)
-6.10% 2017201820192020202120222023202420252026
Debt / equity (×)
2017201820192020202120222023202420252026
EPS ($)
$0.00 -$0.02 -$0.01 $0.00 $0.00 2017201820192020202120222023202420252026

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Gross margin36.8%45.2%11.2%79.8%69.9%
Operating margin20.1%171.4%45.7%-130.4%-39.3%
Net margin16.2%171.4%45.7%-130.4%-39.3%
FCF margin-6.1%
Return on assets-2830.3%-5389.6%-814.4%-543.7%25.2%224.6%3.7%-340.1%
Return on equity9.4%19.3%33.4%173.8%57.7%441.4%323.7%186.4%-1.5%
Current ratio0.000.000.010.141.762.042.040.550.682.85

Computed from company filings · US · as of 2026-01-31. Facts plus Stocktoria's own computed scores — not investment advice.